tirzepatide long term risks is redefining obesity & diabetes care. Dual GIP/GLP-1 action → deeper weight loss, stronger metabolic control, and emerging benefits from OSA to cardiometabolic risk. The era of multi-pathway incretin therapy has Tirzepatide (Zepbound) for weight loss

We're really trying to change societal narrative about this topic without it being polarizing

There are 56 million people who are enrolled in Medicare Part D, according to an analysis from the non-profit health research group KFF

20% of body weight) are more likely to notice hair loss with GLP-1 RA usage.[ref] Studies note that this also occurs with other forms of weight loss, like bariatric surgery, and could be tied to reduced intake of nutrients such as protein, iron, biotin, or zinc

This paradox reveals the intricate link between metabolism, lipid regulation, and cardiovascular health

Ryan PM, Seltzer S, Hayward NE, Rodriguez DA, Sless RT, Hawkes CP

Y.WangL.-F.WuC.-H.KeC.-H.et al (2014)